Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Laparoscopic Ovarian Drilling in PCOS
NCT03009838Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Jan 2017
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of letrozole in infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Assiut University. Primary endpoint: The ovulation rate at 3 months. Status: unknown.
02
Drugs
letrozole
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03009838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03009838.